Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor immunology and immunotherapy.

R B Herberman

    The Laryngoscope
    |May 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Tumor-associated antigens show potential as cancer markers for prognosis and recurrence detection. Immunotherapies aim to boost patient immune responses against these antigens for better cancer treatment outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Tumor immunology.

    JAMA·1992
    Same author

    The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.

    Cancer research·1992
    Same author

    Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ.

    Cancer research·1992
    Same author

    Nongranular proteolytic enzymes of rat IL-2-activated natural killer cells. I. Subcellular localization and functional role.

    Journal of immunology (Baltimore, Md. : 1950)·1992
    Same author

    Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells.

    International journal of cancer·1992
    Same author

    Tissue distribution of adoptively transferred adherent LAK cells: role of the route of administration.

    Natural immunity·1992

    Area of Science:

    • Oncology
    • Immunology
    • Biochemistry

    Background:

    • Tumor cells express unique antigens, including tumor-associated antigens (TAAs).
    • TAAs can serve as diagnostic markers and targets for immune-mediated tumor rejection.
    • Current diagnostic approaches include radioimmunoassays for markers like carcinoembryonic antigen (CEA).

    Purpose of the Study:

    • To evaluate the clinical utility of TAAs in cancer detection, prognosis, and recurrence monitoring.
    • To explore the role of TAAs in mediating host resistance against tumor growth.
    • To review immunotherapeutic strategies aimed at enhancing anti-tumor immunity.

    Main Methods:

    • Review of existing literature on tumor-associated antigens and their detection.
    • Analysis of the clinical utility of carcinoembryonic antigen (CEA) as a tumor marker.

    Related Experiment Videos

  • Examination of immunotherapeutic approaches targeting tumor-associated antigens.

    • Main Results:

    • CEA shows limited promise for initial cancer detection but is valuable for prognosis and detecting recurrent disease.
    • Despite immunosuppression in cancer patients, cell-mediated immunity against TAAs is often present.
    • Various immunotherapeutic strategies are being developed to enhance anti-tumor immune responses.

    Conclusions:

    • Tumor-associated antigens are crucial for understanding cancer biology and developing novel therapeutic strategies.
    • Immunotherapy holds promise for augmenting the host's immune system to combat cancer.
    • Further research into TAAs and immunotherapies can lead to improved cancer management.